GCP
KRRO icon

GSA Capital Partners’s Korro Bio KRRO Stock Holding History

GSA Capital Partners’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5,295
Closed -$1.02M – 1710
2022
Q4 		$1.02M Buy
5,295
+361
+7% +$37.1K 0.13% 198
2022
Q3 		$442K Buy
4,934
+749
+18% +$76K 0.06% 662
2022
Q2 		$314K Sell
4,185
-1,845
-31% -$125K 0.05% 793
2022
Q1 		$639K Buy
6,030
+1,631
+37% +$312K 0.09% 385
2021
Q4 		$1.13M Buy
4,399
+2,766
+169% +$841K 0.14% 152
2021
Q3 		$576K Buy
+1,633
New +$643K 0.06% 616

Other funds holding KRRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
WPW
Waldron Private Wealth Bridgeville, Pennsylvania $2.89B AUM 23.18% 1-Year Est. Return

GSA Capital Partners's KRRO Position: Q1 2023 in Review

GSA Capital Partners sold out of Korro Bio (KRRO) in Q1 2023, closing a stake of 5,295 shares — an estimated $1.02M sold.

GSA Capital Partners first reported a position in KRRO in Q3 2021 and held it in 6 quarters. The position peaked at $1.13M in Q4 2021. 43 funds tracked by Wall St. Rank hold KRRO as of Q1 2023.

  • GSA Capital Partners reported no remaining Korro Bio position as of Q1 2023 after selling out during the quarter.
  • GSA Capital Partners sold 5,295 Korro Bio shares in Q1 2023, an estimated $1.02M.
  • GSA Capital Partners first reported a position in Korro Bio in Q3 2021 and held it in 6 quarters.
  • GSA Capital Partners's Korro Bio position peaked at $1.13M in Q4 2021.
  • 43 funds tracked by Wall St. Rank held Korro Bio as of Q1 2023.

Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.